{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:02:08Z","timestamp":1774479728765,"version":"3.50.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1065","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatitis B virus (HBV) is the most prevalent infectious agent that can induce severe liver disease. Patients infected with long-term HBV, including chronic, asymptomatic and occult forms, cannot clear HBV from infected hepatocytes completely. It is not clear why some people can clear the infection while others cannot. Furthermore, the main mechanisms responsible for progression of the infections are not fully understood. It has been hypothesised that differences in genetic and immunological parameters between patients and subjects who successfully clear HBV infections are responsible for inducing the long-term forms of the infection. Previous investigations showed that Toll-like receptors (TLRs) play important roles in immune responses, especially innate immunity, against viral infections, including hepatitis B. TLR9 detects intracellular viral dsDNA, which results in the activation of an immune response against HBV. However, defects in this system may result in an attenuated response ultimately leading to long-term HBV infections. Targeting the defects in TLR9 or reactivating the downstream pathways that are normally switched on by TLR9 in response to HBV infection is a new approach to the treatment of long-term HBV infection. However, the pathways and defects seen in patients with long-term HBV need to be thoroughly explored before therapeutics can be applied in the clinical setting. Furthermore, the apparently multigenic nature of long-term HBV infection suggests that treatment of patients may need to be personalised.<\/jats:p>","DOI":"10.1136\/postgradmedj-2013-132309","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T08:03:19Z","timestamp":1403078599000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["TLR9: an important molecule in the fight against hepatitis B virus"],"prefix":"10.1093","volume":"90","author":[{"given":"Aziz","family":"Shahrakyvahed","sequence":"first","affiliation":[{"name":"Department of Nursing, Faculty of Nursing and Midwifery, Zabol University of Medical Sciences , Zabol , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Sanchooli","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Zabol University of Medical Sciences , Zabol , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Sanadgol","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, University of Zabol , Zabol , Iran"},{"name":"Faculty of Pharmacy and Pharmaceutical Science Research Center (PSRC), Tehran University of Medical Sciences (TUMS) , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Kazemi","family":"Arababadi","sequence":"additional","affiliation":[{"name":"Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences , Rafsanjan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Kennedy","sequence":"additional","affiliation":[{"name":"School of Natural Sciences, Eskitis Institute for Drug Discovery, Griffith University Nathan , Queensland , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"2023041905564186500_R1","first-page":"1225","article-title":"Occult hepatitis B virus (HBV) infection: a global challenge for medicine","volume":"58","author":"Assar","year":"2012","journal-title":"Clin Lab"},{"key":"2023041905564186500_R2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clinre.2012.11.005","article-title":"Reduced expression of TRIF in chronic HBV infected Iranian patients","volume":"37","author":"Ayoobi","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2023041905564186500_R3","doi-asserted-by":"crossref","first-page":"e7581","DOI":"10.5812\/hepatmon.7581","article-title":"High serum levels of TGF-beta in Iranians with chronic HBV infection","volume":"12","author":"Khorramdelazad","year":"2012","journal-title":"Hepat Mon"},{"issue":"(Suppl 1)","key":"2023041905564186500_R4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1746.2010.06544.x","article-title":"Chronic hepatitis B in Asia\u2014new insights from the past decade","volume":"26","author":"Chan","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"2023041905564186500_R5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1746.2009.05950.x","article-title":"Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients","volume":"25","author":"Arababadi","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"2023041905564186500_R6","first-page":"27","article-title":"Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in the Gambia, West Africa","volume":"27","author":"Mendy","year":"2009","journal-title":"J Viral Hepat"},{"key":"2023041905564186500_R7","first-page":"4","article-title":"Viral hepatitis B and hepatocellular carcinoma","volume":"74","author":"Michielsen","year":"2011","journal-title":"Acta Gastroenterol Belg"},{"key":"2023041905564186500_R8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10753-011-9381-x","article-title":"The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection","volume":"35","author":"Ahmadabadi","year":"2012","journal-title":"Inflammation"},{"key":"2023041905564186500_R9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7754\/Clin.Lab.2013.130206","article-title":"Mutations within the HBc gene of the hepatitis B virus: a study from Iranian patients","volume":"60","author":"Zare-Bidaki","year":"2014","journal-title":"Clin Lab"},{"key":"2023041905564186500_R10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jcb.21119","article-title":"TLR3 signaling in a hepatoma cell line is skewed towards apoptosis","volume":"100","author":"Khvalevsky","year":"2007","journal-title":"J Cell Biochem"},{"key":"2023041905564186500_R11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jor.21369","article-title":"Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles","volume":"29","author":"Hirayama","year":"2011","journal-title":"J Orthop Res"},{"key":"2023041905564186500_R12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/cmi.2011.7","article-title":"Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists","volume":"8","author":"Nguyen-Pham","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"2023041905564186500_R13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ Res"},{"key":"2023041905564186500_R14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/187152811795564064","article-title":"Toll-like receptors: role of inflammation and commensal bacteria","volume":"10","author":"Imani Fooladi","year":"2011","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2023041905564186500_R15","first-page":"277","article-title":"Common variants of the TLR9 gene influence the clinical course of HBV infection","volume":"2","author":"Jia","year":"2009","journal-title":"Mol Med Report"},{"key":"2023041905564186500_R16","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1537-2995.2012.03575.x","article-title":"Current information on the immunological status of occult hepatitis B infection","volume":"52","author":"Arababadi","year":"2012","journal-title":"Transfusion"},{"key":"2023041905564186500_R17","doi-asserted-by":"crossref","first-page":"e7581","DOI":"10.5812\/hepatmon.7581","article-title":"High serum levels of TGF-\u03b2 in Iranians with chronic HBV infection","volume":"12","author":"Khorramdelazad","year":"2012","journal-title":"Hepat Mon"},{"key":"2023041905564186500_R18","first-page":"31","article-title":"Serum levels of interleukin (IL)-10 and IL-17A in occult HBV infected south-east Iranian patients","volume":"10","author":"Arababadi","year":"2010","journal-title":"Hepat Mon"},{"key":"2023041905564186500_R19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"2023041905564186500_R20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ni1028","article-title":"TLR9 signals after translocating from the ER to CpG DNA in the lysosome","volume":"5","author":"Latz","year":"2004","journal-title":"Nat Immunol"},{"key":"2023041905564186500_R21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","article-title":"TLR9 as a key receptor for the recognition of DNA","volume":"60","author":"Kumagai","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"2023041905564186500_R22","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.170.6.3059","article-title":"The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets","volume":"170","author":"Hemmi","year":"2003","journal-title":"J Immunol"},{"key":"2023041905564186500_R23","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1073\/pnas.0501729102","article-title":"Immunomodulatory oligonucleotides containing a cytosine-phosphate-2\u2019-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists","volume":"102","author":"Kandimalla","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023041905564186500_R24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"Bafica","year":"2005","journal-title":"J Exp Med"},{"key":"2023041905564186500_R25","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.4049\/jimmunol.178.8.5182","article-title":"MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection","volume":"178","author":"Copin","year":"2007","journal-title":"J Immunol"},{"key":"2023041905564186500_R26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cellimm.2007.04.003","article-title":"TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae","volume":"245","author":"Lee","year":"2007","journal-title":"Cell Immunol"},{"key":"2023041905564186500_R27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2004.06.007","article-title":"TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function","volume":"21","author":"Krug","year":"2004","journal-title":"Immunity"},{"key":"2023041905564186500_R28","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J Virol"},{"key":"2023041905564186500_R29","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.5858\/arpa.2012-0415-OA","article-title":"Decreased expressions of TLR9 and its signaling molecules in chronic HBV infected patients","volume":"137","author":"Sajadi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"2023041905564186500_R30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/infdis\/jis420","article-title":"Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan","volume":"206","author":"Wu","year":"2012","journal-title":"J Infect Dis"},{"key":"2023041905564186500_R31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08941939.2012.687802","article-title":"Toll-like receptor signaling in liver ischemia and reperfusion","volume":"25","author":"Chang","year":"2012","journal-title":"J Invest Surg"},{"key":"2023041905564186500_R32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4149\/gpb_2012_048","article-title":"Molecular biology of toll-like receptors","volume":"31","author":"Szatmary","year":"2012","journal-title":"Gen Physiol Biophys"},{"key":"2023041905564186500_R33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","article-title":"Toll-like receptor signaling in cell proliferation and survival","volume":"49","author":"Li","year":"2010","journal-title":"Cytokine"},{"key":"2023041905564186500_R34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2010.09.005","article-title":"NF-kappaB family of transcription factors: biochemical players of CD28 co-stimulation","volume":"135","author":"Tuosto","year":"2011","journal-title":"Immunol Lett"},{"key":"2023041905564186500_R35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01051.x","article-title":"Cytoplasmic DNA innate immune pathways","volume":"243","author":"Barber","year":"2011","journal-title":"Immunol Rev"},{"key":"2023041905564186500_R36","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.175.7.4635","article-title":"Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection","volume":"175","author":"Alsharifi","year":"2005","journal-title":"J Immunol"},{"key":"2023041905564186500_R37","first-page":"584","article-title":"Recognition of HBV antigens and HBV DNA by dendritic cells","volume":"9","author":"Cui","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2023041905564186500_R38","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.23602","article-title":"Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"key":"2023041905564186500_R39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.21897","article-title":"Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice","volume":"46","author":"Wu","year":"2007","journal-title":"Hepatology"},{"key":"2023041905564186500_R40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"2023041905564186500_R41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00011-012-0493-z","article-title":"Downregulation of TLR7\/9 leads to deficient production of IFN-alpha from plasmacytoid dendritic cells in chronic hepatitis B","volume":"61","author":"Xu","year":"2012","journal-title":"Inflamm Res"},{"key":"2023041905564186500_R42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cellimm.2012.09.005","article-title":"Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B","volume":"279","author":"Ratnam","year":"2012","journal-title":"Cell Immunol"},{"key":"2023041905564186500_R43","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.humimm.2010.07.013","article-title":"Correlation of TLR1\u201310 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure","volume":"71","author":"Wang","year":"2010","journal-title":"Hum Immunol"},{"key":"2023041905564186500_R44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11596-009-0310-2","article-title":"Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads","volume":"29","author":"Zhou","year":"2009","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2023041905564186500_R45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.micinf.2009.02.008","article-title":"Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9","volume":"11","author":"Xie","year":"2009","journal-title":"Microbes Infect"},{"key":"2023041905564186500_R46","doi-asserted-by":"crossref","first-page":"e44900","DOI":"10.1371\/journal.pone.0044900","article-title":"HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS ONE"},{"key":"2023041905564186500_R47","doi-asserted-by":"crossref","first-page":"e55487","DOI":"10.1371\/journal.pone.0055487","article-title":"Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1\/STAT3 signaling pathway","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"2023041905564186500_R48","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.molimm.2009.04.031","article-title":"HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells","volume":"46","author":"Xu","year":"2009","journal-title":"Mol Immunol"},{"key":"2023041905564186500_R49","doi-asserted-by":"crossref","first-page":"e26315","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PLoS ONE"},{"key":"2023041905564186500_R50","doi-asserted-by":"crossref","first-page":"e15324","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS ONE"},{"key":"2023041905564186500_R51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.it.2010.07.004","article-title":"Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer","volume":"31","author":"Hirsch","year":"2010","journal-title":"Trends Immunol"},{"key":"2023041905564186500_R52","first-page":"277","article-title":"Common variants of the TLR9 gene influence the clinical course of HBV infection","volume":"2","author":"Jia","year":"2009","journal-title":"Mol Med Rep"},{"key":"2023041905564186500_R53","first-page":"941","article-title":"Hepatitis B virus DNA-`induced carcinogenesis of human normal liver cells by virtue of nonmethylated CpG DNA","volume":"21","author":"Liu","year":"2009","journal-title":"Oncol Rep"},{"key":"2023041905564186500_R54","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","article-title":"The role of miRNAs in regulating gene expression networks","volume":"425","author":"Gurtan","year":"2013","journal-title":"J Mol Biol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1065\/396\/50003217\/postgradmedj-90-396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1065\/396\/50003217\/postgradmedj-90-396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:06:21Z","timestamp":1681884381000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/90\/1065\/396\/6992137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":54,"journal-issue":{"issue":"1065","published-online":{"date-parts":[[2014,6,18]]},"published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2013-132309","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,7]]},"published":{"date-parts":[[2014,6,18]]}}}